Lufenuron

Lufenuron

SCHEMBL29350147

O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 1.00
MEN1 O00255 4/20 1.00
MAPT P10636 2/20 1.00
USP2 O75604 1/20 1.00
ALOX15 P16050 1/20 1.00
POLB P06746 1/20 0.49
ATM Q13315 1/20 0.46
RECQL P46063 2/20 0.41
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TLR7 Q9NYK1 1/20 0.38
GAA P10253 2/20 0.38
THRB P10828 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PYGL P06737 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
DHODH Q02127 1/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
IL2 P60568 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lufenuron SCHEMBL4131569 1.00 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL29850969 1.00 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL15555900 1.00 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL27105 1.00 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL28709254 1.00 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL7587434 0.94 KMT2A (0.88) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL9990506 0.93 KMT2A (0.87) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL7591855 0.92 KMT2A (0.85) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL19643246 0.91 MEN1 (0.83) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL7585954 0.91 KMT2A (0.83) KMT2AMEN1MAPTUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022093977-A1 PATHOGEN RESISTANCE IN PLANTS Fortiphyte, Inc. (US) 2022-05-05 WO claimed
EP-4735470-A1 SYSTEMS AND METHODS FOR NEGATIVE PRESSURE GRAIN IMBIBITION Smart Sprouts International LLC (US) 2026-05-06 EP disclosed
US-20260117244-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-04-30 US disclosed
EP-4728079-A1 PLANTS WITH MODIFIED FATTY ACID AND/OR OIL CONTENT Confluence Genetics, LLC (US) 2026-04-22 EP disclosed
US-12602731-B1 Authentication-credential identification and selection for access to secure statements Ardent Labs, Inc (US) 2026-04-14 US disclosed
US-20260098960-A1 ASSESSMENT OF BUILDING DAMAGES UNDER DIFFERENT GROUND SETTLEMENT MOVEMENTS USING MT-INSAR MONITORING TECHNIQUE UNIV HONG KONG CHINESE (CN) 2026-04-09 US disclosed
US-12572984-B1 Embedded communication in an insurance brokerage accounting system Ardent Labs, Inc (US) 2026-03-10 US disclosed
US-12572520-B2 Machine-learning-automated recognition and labelling of columnar data EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (US) 2026-03-10 US disclosed
US-12555653-B2 Digital healthcare capture intake data for COVID-19 and other significant events DERSHEM MICHAEL (US) 2026-02-17 US disclosed
US-20260041087-A1 LIPID NANOPARTICLE FORMULATIONS FOR AGRICULTURAL APPLICATIONS INVAIO SCIENCES INC (US) 2026-02-12 US disclosed
WO-2022087451-A1 NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF THE BROAD INSTITUTE, INC. (US) 2022-04-28 WO disclosed
EP-3984179-A1 INTENT BASED APPLICATION FABRIC Cisco Technology, Inc. (US) 2022-04-20 EP disclosed
US-11289189-B2 Systems and methods for auto-generation of telemedicine clinics AZOVA, INC. (US) 2022-03-29 US disclosed
WO-2022053453-A1 AZOLE CARBOXAMIDE AS PEST CONTROL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2022-03-17 WO disclosed
EP-3965573-A1 HIGH SPREADING AND UPTAKE ULV FORMULATIONS Bayer Aktiengesellschaft (DE) 2022-03-16 EP disclosed
WO-2022049498-A1 FORMULATIONS AND METHODS FOR REGULATING AND STIMULATING PLANT GROWTH UPL LIMITED (IN) 2022-03-10 WO disclosed
US-11269072-B2 Land deformation measurement THE UNIVERSITY OF NOTTINGHAM (GB) 2022-03-08 US disclosed
US-20220048873-A1 PESTICIDALLY ACTIVE CYCLOPROPYL METHYL AMIDE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-02-17 US disclosed
US-11250530-B1 Method and system for consumer based access control for identity information Acceptto Corporation (US) 2022-02-15 US disclosed
CN-113966595-A Intent-based application architecture 思科技术公司 2022-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12602731-B1 Authentication-credential identification and selection for access to secure statements SLC10A2, ITGB8, INTS6 KMT2A 1482/4885MEN1 2289/4885MAPT 4829/4885
US-20220048873-A1 PESTICIDALLY ACTIVE CYCLOPROPYL METHYL AMIDE DERIVATIVES ACHE, PNMT, DDT KMT2A 1687/4885MEN1 2176/4885MAPT 260/4885
US-12555653-B2 Digital healthcare capture intake data for COVID-19 and other significant events DPP4, PURB, HBB KMT2A 4023/4885MEN1 2114/4885MAPT 1539/4885
US-20260117244-A1 INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS ATG13, MAVS, ATG7 KMT2A 3748/4885MEN1 4861/4885MAPT 3269/4885
US-12572984-B1 Embedded communication in an insurance brokerage accounting system SEC63, LSM8, BAG2 KMT2A 2224/4885MEN1 2734/4885MAPT 4651/4885
US-20260041087-A1 LIPID NANOPARTICLE FORMULATIONS FOR AGRICULTURAL APPLICATIONS PLTP, CETP, PLIN1 KMT2A 2626/4885MEN1 1090/4885MAPT 167/4885
US-20260098960-A1 ASSESSMENT OF BUILDING DAMAGES UNDER DIFFERENT GROUND SETTLEMENT MOVEMENTS USING MT-INSAR MONITORING TECHNIQUE MRE11, MTNR1A, DSP KMT2A 2548/4885MEN1 874/4885MAPT 2556/4885
US-12572520-B2 Machine-learning-automated recognition and labelling of columnar data SET, HLA-DRB1, COL2A1 KMT2A 1091/4885MEN1 732/4885MAPT 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.